-
Part 3 | Session 1 Population Strategies for the Management of Hypertension
-
Part 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins
-
Part 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
-
Part 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
-
Part 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events
-
Part 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes
-
Part 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM
-
Part 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial
-
Part 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial
-
Part 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Late-breaker Discussion Series
Part 2
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 3
Expert Interviews
Faculty Biographies
Nicolas M Van Mieghem
Full Professor of Interventional Cardiology
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
Academic History
Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.